Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133662) titled 'A Study on the Efficacy and Safety of Linaprazan Glurate in the Treatment of Reflux Hypersensitivity (RH)' on Sept. 30.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Reflux Hypersensitivity
Intervention:
Control group:Take PPI
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Control group:30;Experimental Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345844
Pub...